Analyst Ratings for Moderna (MRNA)
MRNA Rating Summary
MRNA Price Target Summary
- Highest: $231.00 (Goldman Sachs)
- Lowest: $68.00 (Leerink Partners)
- Average: $136.53
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$136.53 (+69.4%)
* Over Last 12-Mos
Rating Score: 3.7 / 10
Percentile Rank: 35%
Rating Score: 3.7 / 10

Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/29/2023 | Canaccord Genuity | Bill Maughan | New Coverage | Hold (N/A) |
82.00 (N/A) |
77.72 (80.60) |
3.71% | Details |
11/3/2023 | HSBC | Yifeng Liu | Upgrade | Hold (Reduce) |
69.00 (89.00) |
76.20 (80.60) |
5.77% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |